NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 1.9% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.28% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.23% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.22% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 1.21% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.21% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.19% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.19% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 1.19% |
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 1.19% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 1.19% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.18% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.16% |
| GERN | Geron Corporation | Healthcare | Biotechnology | 1.15% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 1.15% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 1.14% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.14% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.13% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.12% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.11% |
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).